A study published in October 2026 in the Journal of Dairy Science, Volume 109, Issue 10, reports that administering recombinant bovine somatotropin (rbST) at the initiation of embryo-transfer synchronization — but not at the time of embryo transfer itself — enhances fertility in embryo-recipient heifers.

The paper, titled "Recombinant bovine somatotropin at synchronization initiation, but not at embryo transfer, enhances fertility in embryo-recipient heifers: Associations with follicular, luteal, and embryonic outcomes," was authored by Lígia Mattos Rebeis, Pietro Sampaio Baruselli, Hattie Harden, Alanis A. Perez, Marco R. Dalalio, Meliton Fosado, Juan F. Moreno, Pablo J. Ross, and Victor E. Gomez-Leon.

Why does timing matter?

The title finding carries a practical distinction for practitioners managing recipient programs. The benefit, as reported by the authors, attaches to the earlier intervention point: rbST given when the synchronization protocol begins. Giving rbST at embryo transfer — the later opportunity many protocols might consider — did not produce the same fertility enhancement in this study population.

That asymmetry is the headline. For herd veterinarians, it suggests the window for a metabolic or endocrine effect on recipient fertility opens before the embryo arrives, not at the moment of transfer.

What physiological outcomes did the authors track?

The subtitle of the study signals the mechanism-focused design. The authors examined associations between rbST treatment and three outcome domains:

• Follicular outcomes — ovarian follicle dynamics during the synchronization period
• Luteal outcomes — corpus luteum development and function in recipients
• Embryonic outcomes — results tied to the transferred embryos themselves

By framing the fertility effect alongside these physiological measures, the study connects the field-level result — better fertility in recipients — with the reproductive biology that plausibly drives it.

Food-animal practice implications

This is a food-animal story, specifically dairy and embryo-transfer program management. The findings are relevant to:

• Veterinarians designing synchronization protocols for embryo-recipient heifers
• Embryo-transfer services deciding where, or whether, to add rbST to recipient management
• Producers evaluating whether an additional handling event at synchronization is justified by fertility returns

Note the regulatory frame: rbST is an established tool in dairy production, and this study addresses its application in a reproductive-protocol context rather than its approval status. Practitioners should follow label and jurisdictional rules for rbST use in their markets, as the study itself does not alter any regulatory position.

What the study does and does not claim

The authors' own framing is association-based. The title reports "associations with follicular, luteal, and embryonic outcomes," which places the physiological findings as linked correlates of the fertility enhancement rather than, on the face of the title, as independently proven mechanisms. Readers seeking effect sizes, sample sizes, and the specific synchronization protocol used should consult the full text in Journal of Dairy Science, Volume 109, Issue 10.

The bottom line

One decision changes at the barn: if a program is going to use rbST in recipient heifers, this study points to synchronization initiation as the effective moment — not the transfer day. Full methodological detail, including the herd numbers and protocol specifications needed to evaluate on-farm applicability, appears in the October 2026 issue of the Journal of Dairy Science.